文献速递重症综合管理与镇静镇痛心脑血管急症

脓毒症患者的院内神经系统并发症、神经监测与长期神经功能结局:一项系统评价与荟萃分析

In-Hospital Neurologic Complications, Neuromonitoring, and Long-Term Neurologic Outcomes in Patients With Sepsis: A Systematic Review and Meta-Analysis.
PubMed 文献 · Crit Care Med · 2023-11-03
一句话结论脓毒症患者院内神经系统并发症常见,脓毒性脑病发生率为36%(95%CI 27-46%),但机制与标准化神经监测数据有限。

该系统评价与荟萃分析检索7个数据库至2023年1月,纳入74项研究共146,855例成人脓毒症患者。神经系统并发症在38项研究(n=142,193)中报告:脓毒性脑病36%(95%CI 27-46%;I²=99%)、缺血性卒中5%、颅内出血2%、癫痫1%、后可逆性脑病综合征9%、缺氧缺血性脑损伤7%。3项研究(n=159)报告尸检神经病理,47%存在急性脑损伤;26项研究(n=1,358)报告神经监测工具使用,脑电图最常用于癫痫检测。6项研究(n=415)报告出院后12个月内认知结局,30%存在认知障碍(≥1个领域)。作者结论认为机制与时机不明,标准化神经监测数据有限。

要点

  • 脓毒性脑病是脓毒症患者最常见的院内神经系统并发症,发生率为36%(95%CI 27-46%;I²=99%)。
  • 缺血性卒中5%(95%CI 2.1-11.5;I²=99%)、颅内出血2%(95%CI 1.0-4.4%;I²=96%)、癫痫1%(95%CI 0.2-7%;I²=96%)。
  • 多重回归分析显示肺部感染、革兰阳性菌所致脓毒症、较高的SOFA评分、入院时APACHE II评分及较长ICU住院时间与脓毒性脑病风险升高相关。
  • 26项研究(n=1,358)报告神经监测工具,脑电图最常用于癫痫检测,经颅多普勒和近红外光谱用于监测脑血流动力学变化以检测早期缺血。
  • 6项研究(n=415)报告出院后12个月内认知结局,30%存在认知障碍(≥1个领域)。

适用人群与场景

  • 成人脓毒症患者。
  • 研究纳入报告神经系统并发症、神经监测工具使用、神经病理或认知结局的成人脓毒症研究。

研究设计与关键结果

  • 系统评价与荟萃分析,纳入74项研究(n=146,855),检索MEDLINE等7个数据库至2023年1月,采用随机效应模型合并数据。
  • 神经系统并发症在38项研究(n=142,193)中报告:脓毒性脑病36%(95%CI 27-46%;I²=99%),缺血性卒中5%(95%CI 2.1-11.5;I²=99%),颅内出血2%(95%CI 1.0-4.4%;I²=96%),癫痫1%(95%CI 0.2-7%;I²=96%),后可逆性脑病综合征9%,缺氧缺血性脑损伤7%。
  • 多重回归分析显示肺部感染、革兰阳性菌所致脓毒症、较高的SOFA评分、入院时APACHE II评分及较长ICU住院时间与脓毒性脑病风险升高相关。
  • 3项研究(n=159)报告尸检神经病理,47%存在急性脑损伤。
  • 26项研究(n=1,358)报告神经监测工具使用,脑电图最常用于癫痫检测,经颅多普勒和近红外光谱用于监测脑血流动力学变化以检测早期缺血。
  • 6项研究(n=415)报告出院后至12个月的认知结局,30%存在认知障碍(≥1个领域)。

证据类型、等级与局限

  • 证据类型:系统评价与荟萃分析,纳入74项研究(n=146,855)。
  • 局限:脓毒性脑病合并患病率异质性I²=99%,缺血性卒中I²=99%,颅内出血I²=96%,癫痫I²=96%。
  • 局限:原文未报告标准化神经监测数据,机制与时机了解有限。

对床旁实践的改变

  • 脓毒症患者应警惕院内神经系统并发症,脓毒性脑病发生率为36%(95%CI 27-46%),缺血性卒中5%、颅内出血2%、癫痫1%。
  • 脑电图是脓毒症患者癫痫检测最常用的神经监测工具;经颅多普勒和近红外光谱可用于监测脑血流动力学变化以检测早期缺血。
  • 出院后12个月内30%的脓毒症患者存在认知障碍(≥1个领域),需关注长期神经认知结局。
  • 作者认为脓毒症相关神经系统并发症的机制与时机尚不清楚,标准化神经监测数据有限。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Although delirium is well described in patients with sepsis, there are limited data on other neurologic complications. We aimed to systematically review the prevalence, neuromonitoring tools, and neurocognitive outcomes in sepsis patients with neurologic complications.

DATA SOURCES: MEDLINE and six other databases (Embase, Web of Science, Cochrane CENTRAL, and ClinicalTrials.gov ) were searched through January 2023.

STUDY SELECTION: Studies of adult patients with sepsis reported neurologic complications, use of neuromonitoring tools, neuropathology, and cognitive outcomes.

DATA EXTRACTION: Two independent reviewers extracted the data. Random-effect meta-analyses were used to pool data.

DATA SYNTHESIS: Seventy-four studies ( n = 146,855) were included. Neurologic complications were reported in 38 studies ( n = 142,193) including septic encephalopathy (36%, 95% CI, 27-46%; I 2 = 99%), ischemic stroke (5%, 95% CI, 2.1-11.5; I 2 = 99%), intracranial hemorrhage (2%, 95% CI, 1.0-4.4%; I 2 = 96%), seizures (1%, 95% CI, 0.2-7%; I 2 = 96%), posterior reversible encephalopathy syndrome (9%), and hypoxic-ischemic brain injury (7%). In the meta-regression analysis, pulmonary infection, sepsis induced by a gram-positive organism, higher sequential organ failure assessment score, acute physiology and chronic health evaluation II score at admission, and longer ICU length of stay were associated with higher risk of developing septic encephalopathy. Three studies ( n = 159) reported postmortem neuropathological findings, acute brain injury was noted in 47% of patients. Twenty-six studies ( n = 1,358) reported the use of neuromonitoring tools, electroencephalogram was the most used tool for seizure detection. Transcranial Doppler and near infrared spectroscopy were used for monitoring cerebral hemodynamic changes to detect early ischemia. Six studies reported cognitive outcomes ( n = 415) up to 12 months postdischarge and cognitive impairment (≥ one domain) was reported in 30%.

CONCLUSIONS: In-hospital neurologic complications are common in patients with sepsis. However, the mechanism and timing of those sepsis-associated complications are poorly understood and there are limited data on standardized neuromonitoring in this population.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Fan TH, Premraj L, Roberts J, et al. In-Hospital Neurologic Complications, Neuromonitoring, and Long-Term Neurologic Outcomes in Patients With Sepsis: A Systematic Review and Meta-Analysis. Crit Care Med. 2023. PMID: 37921513. doi:10.1097/CCM.0000000000006096

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。